WebVMC and Home Telehealth Ltd. Form Partnership in Europe

WebVMC, developer of the RemoteNurse™ telehealth system that enables 24 hour virtual medical care for remote disease management, has entered into an exclusive partnership with Home Telehealth Ltd., (HTL) one of the United Kingdom's leading providers of telehealth products and managed care services. HTL will distribute WebVMC's software-based telehealth monitoring product in the United Kingdom and the 25 EU countries. The announcement was made by Scott Sheppard, President and Chief Technology Officer of WebVMC and Peter Range, Chief Executive Officer of HTL.

"We selected WebVMC as we feel it is clearly the 'best of breed' technology available in home healthcare monitoring, empowering those with long-term conditions to do more to care for themselves," said Range. "Their program is user-friendly and easily adaptable for use in multiple settings via a variety of IT platforms. WebVMC supplies the intelligent software that sits behind the monitoring devices to enable true 24/7 disease management anytime and anywhere. With WebVMC, we are confident that health care providers will be able to deliver better community-based care to the most at risk patients while improving the lives of those with complex needs, achieving gains in quality of life and reductions in acute hospital use."

RemoteNurse

The RemoteNurse™ has obtained the required EC Declaration of Conformity, EC Declaration of Mutual Compatibility and MHRA registration (equivalent to the FDA approval required in the United States), which allows their product to be sold in all EU nations, Canada and Mexico. WebVMC's expansion into international markets will assist HTL in its efforts to provide telehealth solutions with a strong emphasis on patient education and empowerment, so that people are fully informed about their condition and are better able to manage it.

WebVMC's Sheppard said the main distinction between other telehealth options and his company's product is its unique features which include multi-patient, multi-language, multi-platform and customizable disease management capability. "Most telehealth products simply provide disease monitoring through existing systems," Sheppard stated. "But our software-based technology offers increased connectivity and the ability to access health care data via the Internet which allows patients at home to obtain a speedy intervention if their health deteriorates. This timely response could prevent an unnecessary hospitalization and allows the person to stay at home and remain independent."

The demand for telehealth technology and services in the United Kingdom has increased significantly due to recent government Preventative Technology Grant (PTG) funding and forthcoming Whole System Long-Term Conditions demonstrators. The British government recognized that an aging population, rapidly rising health and social care costs and a shortage of health and social care professionals required a new vision and delivery of care in the community. Currently in the UK, over 70 percent of health care costs are spent on people over age 65; 80 percent of those people have at least one chronic illness, most commonly respiratory disease, heart disease, diabetes and hypertension.

The recent shift of emphasis from providing residential care for older people to offering services to help them to remain independent in their own homes has resulted in a three percent reduction in the number of people 65 and over in supported care as of March 2006. HTL's Range cited current data indicating that telehealth programmes have reduced hospital admissions by 38 percent and reduced bed utilization by 56 percent among patients with congestive heart failure and chronic obstructive pulmonary disease, through the use of home patient monitoring technology. Additionally, government figures estimate that a greater use of telehealth technology could produce savings in excess of £100 million per year.

Consequently, approximately £140 million in grant funds have been designated in the UK to develop new and better telecare technologies and managed services to enhance and maintain the well being, self-esteem and independence of individuals.

About WebVMC
WebVMC provides virtual healthcare technology using the Internet to manage care for the person with a chronic illness, connecting the patient, caregiver and clinician for 24 hour disease management from any location, in multiple healthcare delivery systems—home care, hospitals and assisted living facilities. With innovative capabilities, such as audio tracks, touch-screen access and instant messaging, WebVMC's products are user-friendly, comprehensive solutions that cost-effectively manage patients with chronic illness for better health status and better quality of life. For more information about WebVMC, visit www.webvmc.com, or contact Bill Behnke, (210) 240-9400, This email address is being protected from spambots. You need JavaScript enabled to view it..

About Home Telehealth Limited
Home Telehealth Limited (HTL) provides telehealth technology and managed service provision for home monitoring applications to several NHS PASA NFA for Telecare suppliers. It has eight years experience in implementing programmes for telecare, telehealth and telemedicine bringing the necessary 'hands on' assistance to organisations looking to commence telehealth and telecare programmes for the first time. HTL has offices in Wales (Cardiff) and England. For more information on HTL please visit www.hometelehealthltd.co.uk, email:This email address is being protected from spambots. You need JavaScript enabled to view it. or call David Muxworthy on 02920-444-795

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Record Year with More than 800 Exhibit…

9 - 11 April 2024, Berlin, Germany. DMEA 2024 kicks off today, focusing on the key issues in the digital transformation of the healthcare system. From now until 11 April over...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...